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A B S T R A C T   
This secondary analysis of the PHOENIX trial (evaluating planned delivery against expectant management in late 
preterm preeclampsia) demonstrates that in women who started induction of labour, 63% of women delivered 
vaginally (56% at 34 weeks’ gestation). Compared to expectant management, planned delivery was associated 
with higher rates of neonatal unit admission for prematurity (but lower proportions of small-for-gestational age 
infants); length of neonatal unit stay and neonatal morbidity (including respiratory support) were similar across 
both intervention groups at all gestational windows. Neonatal unit admission was increased by earlier gestation 
at delivery, development of severe preeclampsia, and being small-for-gestational age.   
1. Introduction 
National guidance in the UK for women with late preterm pre-
eclampsia recommends expectant management until 37 weeks’ gesta-
tion, with intervention only if the woman develops severe preeclampsia 
or associated complications [1]. The PHOENIX (Planned early delivery 
or expectant management for late preterm preeclampsia) trial was a 
large, multicentre, randomised controlled trial comparing planned de-
livery with expectant management in 901 women with preeclampsia 
between 34 and 37 weeks’ gestation [2]. This trial demonstrated that 
planned delivery reduced maternal morbidity and severe hypertension 
compared to expectant management. However, planned delivery was 
also found to be associated with an increase in neonatal unit admission 
related to prematurity, but with no evidence of greater neonatal 
morbidity. The aim of this planned secondary analysis was to evaluate 
the likelihood of successful vaginal delivery after induction of labour 
and to determine factors associated with neonatal unit admission, 
stratified by gestational age. 
2. Methods 
This was a planned secondary analysis of the PHOENIX trial (ISRCTN 
01879376), and full details of the trial can be found within the protocol 
[3] and published short-term results [2]. Women aged 18 years and 
above with confirmed preeclampsia or superimposed preeclampsia [4] 
between 34+0 and 36+6 weeks’ gestation were recruited from 46 ma-
ternity units across England and Wales. Participants were randomly 
allocated to planned delivery (within 48 h of randomisation to allow for 
corticosteroid administration and neonatal cot availability if necessary) 
or expectant management using a 1:1 ratio. The main trial results have 
been reported.2 Action on Pre-eclampsia, the national patient support 
charity, advised on the design of this secondary analysis to ensure that 
relevant outcomes were studied. 
Vaginal delivery after induction of labour was defined as sponta-
neous or assisted vaginal delivery after induction of labour. For evalu-
ation of neonatal unit admission, all infants were included in this 
analysis. Infant characteristics were described by randomisation group 
and by week of gestational age at randomisation. Maternal and infant 
risk factors for neonatal unit admission were estimated using logistic 
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regression, expressed as odds ratios with 95% confidence intervals as 
appropriate. Randomisation group was included as a potential factor 
(with all infants analysed according to the group into which their 
mother was allocated). Significant predictors including trial allocation, 
severe maternal hypertension, severe preeclampsia, gestation at de-
livery, small-for-gestational age, mode of delivery and administration of 
antenatal corticosteroids were adjusted for, and the adjusted estimates 
were considered primary with regards to inference. 
Table 1 
Mode of delivery and principal recorded indication for neonatal unit admission by gestation at randomisation and trial allocation.   













Maternal outcomes N ¼ 131 N ¼ 135 N ¼ 136 N ¼ 131 N ¼ 180 N ¼ 184 
Mode of delivery       
Pre-labour caesarean section 47 (36%) 65 (48%) 56 (41%) 38 (29%) 37 (21%) 49 (27%) 
Vaginal 46 (35%) 42 (31%) 44 (40%) 53 (40%) 102 (57%) 89 (48%) 
Emergency caesarean section 38 (29%) 28 (21%) 26 (19%) 40 (31%) 41 (23%) 46 (25%) 
Mode of delivery (following 
induction)       
Vaginal 46/83 (55%) 36/63 (57%) 54/81 (67%) 49/86 (57%) 100/142 (70%) 82/124 (66%) 
Emergency caesarean section 37/83 (45%) 27/63 (43%) 27/81 (33%) 37/86 (43%) 42/142 (30%) 42/124 (34%) 
Infant outcomes N ¼ 136 N ¼ 143 N ¼ 148 N ¼ 141 N ¼ 187 N ¼ 191 
Median (IQR) gestation at delivery 
(days) 
243 (241–245) 247 (243–254) 250 (248–252) 256 (252–259) 258 (256–260) 260 (259–262) 
Gestation at delivery ≥ 37 weeks 1 (<1%) 21 (15%) 4 (3%) 49 (37%) 77 (43%) 144 (78%) 
Birthweight       
Median (IQR) birthweight (g) 2085 
(1868–2403) 
2171 (1971–2464) 2318 
(2054–2690) 
2400 (2140–2830) 2660 
(2450–2915) 
2720 (2473–3090) 
Median (IQR) birthweight centile [7] 33 (15–60) 26 (11–46) 30 (14–59) 30 (12–59) 42 (20–65) 42 (18–74) 
Birthweight less than tenth centile [7] 22 (16%) 35 (25%) 30 (20%) 32 (23%) 22 (12%) 28 (15%) 
Neonatal unit admission       
Infants admitted to neonatal unit 96 (71%) 81 (57%) 66 (45%) 43 (31%) 34 (18%) 35 (18%) 
Median (IQR) total days in neonatal 
unit 
7 (3–12) 11 (4–15) 4 (2–10) 4 (1–8) 3 (1–8) 4 (1–7) 
Principal indication for admission       
Prematurity 54/96 (56%) 29/81 (36%) 27/66 (41%) 10/43 (23%) 2/34 (6%) 1/35 (3%) 
Respiratory disease 25/96 (26%) 19/81 (23%) 12/66 (18%) 10/43 (23%) 10/34 (29%) 12/35 (34%) 
Hypoglycaemia 7/96 (7%) 12/81 (15%) 8/66 (12%) 11/43 (26%) 6/34 (18%) 8/35 (23%) 
Jaundice 2/96 (2%) 4/81 (5%) 5/66 (8%) 4/43 (9%) 5/34 (15%) 3/35 (9%) 
Infection suspected/ confirmed 1/96 (1%) 6/81 (7%) 4/66 (6%) 2/43 (5%) 4/34 (12%) 4/35 (11%) 
IUGR/ SGA 3/96 (3%) 6/81 (7%) 4/66 (6%) 3/43 (7%) 1/34 (3%) 1/35 (3%) 
Other 4/96 (4%) 5/81 (6%) 6/66 (9%) 3/43 (7%) 6/34 (18%) 6/35 (17%) 
Neonatal morbidity (recorded at 
discharge)       
Need for respiratory support 24 (18%) 29 (20%) 11 (7%) 9 (6%) 10 (5%) 10 (5%) 
Hypoglycaemia 34 (25%) 34 (24%) 24 (16%) 23 (16%) 22 (12%) 15 (8%) 
Data are median (IQR) or n (%) unless otherwise stated. IQR: interquartile range. IUGR: intrauterine growth restriction. SGA: Small for gestational age. 
Table 2 
Effect of maternal and infant characteristics on neonatal unit admission. N = all infants unless otherwise stated.   
Number of infants 
(N) 
Neonatal unit admission 
(n, %) 
Unadjusted odds ratio 
(95% CI) 
Adjusted odds ratio* (95% 
CI) 
Trial allocation     
Planned delivery (vs expectant management) 471 196 (42%) 1.43 (1.10–1.86) 0.98 (0.70–1.35) 
Maternal characteristics     
Maternal diabetes (pre- and gestational) (vs none) 163 66 (40%) 1.16 (0.82–1.63) – 
Maternal severe hypertension before delivery (≥160 
mmHg) (vs none) 
611 249 (41%) 1.47 (1.11–1.96) 0.52 (0.26–1.04) 
Progression to severe preeclampsia (vs none) 655 270 (41%) 1.68 (1.25–2.27) 2.35 (1.14–4.79) 
Infant characteristics     
SGA (<10th centile) 169 94 (56%) 2.47 (1.76–3.47) 3.11 (2.12–4.58) 
Twin pregnancy (vs singleton) 94 32 (34%) 0.87 (0.55–1.36) – 
Gestation at delivery     
≥37 weeks 296 50 (17%) Referent – 
36 weeks 297 87 (29%) 2.04 (1.38–3.04) 2.09 (1.36–3.23) 
35 weeks 215 106 (49%) 2.78 (3.21–7.22) 4.65 (2.91–7.52) 
34 weeks 136 112 (82%) 22.96 (13.66–39.97) 25.52 (14.06–47.92) 
Delivery     
ACS given (vs ACS not given) 575 260 (45%) 2.43 (1.83–3.25) 0.96 (0.67–1.39) 
Mode of delivery     
Vaginal delivery 394 113 (29%) Referent – 
Pre-labour CS 322 150 (47%) 2.17 (1.59–2.96) 1.36 (0.94–1.98) 
Emergency CS 228 92 (40%) 1.68 (1.19–2.37) 1.40 (0.94–2.08) 
*Estimates calculated using multivariable logistic regression, adjusted for variables that were significant on univariable analysis (shown in unadjusted odds ratio 
column): trial allocation, maternal severe hypertension, progression to severe preeclampsia, SGA, gestation at delivery, ACS given, mode of delivery. SGA: Small for 
gestational age. ACS: antenatal corticosteroids. CS: Caesarean section. 
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All statistical analyses were performed using R, version 4.0.3. 
3. Results 
Of 901 women recruited, 897 women were included in this analysis 
(2 withdrew consent and there were missing data for this analysis for 2 
women), of which 447 were randomised to planned delivery and 450 to 
expectant management. Baseline characteristics for these women are 
presented in Supplementary Table 1. 579 of these women underwent 
induction of labour and 367 of these (63%) had a vaginal delivery. Rates 
of vaginal (assisted or spontaneous) delivery were similar in the planned 
delivery (200/304; 66%) and expectant management (167/275; 61%) 
groups (adjusted Risk Ratio (aRR) 1.08, 95% CI 0.96–1.22). In the trial, 
56.1% of women undergoing induction of labour at 34 weeks, 61.6% at 
35 weeks and 68.4% at 36 weeks delivered vaginally. Vaginal delivery 
rates were similar between those allocated to planned delivery or 
expectant management when stratified by gestational weeks at enrol-
ment (Table 1). 
In women randomised to planned delivery, a higher proportion of 
infants were admitted to the neonatal unit at 34 (71% vs 57%) and 35 
(45% vs 31%) weeks, compared with those women allocated to expec-
tant management, though not at 36 weeks (both 18%). Median birth-
weight centile was greater in infants born to women randomised to 
planned delivery at 34 weeks (33 vs 26), but not at 35 or 36 weeks. 
Across all gestations, planned delivery was associated with fewer babies 
born small-for-gestational age (<10th centile) compared to those allo-
cated to expectant management (16% vs 25% at 34 weeks, 20% vs 23% 
at 35 weeks, 12% vs 15% at 36 weeks). Neonatal unit length of stay, 
need for respiratory support and hypoglycaemia (assessed through 
recording at discharge) were similar between planned delivery and 
expectant management groups, at all gestational ages. Predictors at 
delivery for neonatal unit admission included progression to severe 
preeclampsia (adjusted Odds Ratio (aOR) 2.35, 95% CI 1.14–4.58), 
being small-for-gestational age (aOR 3.11, 95% CI 2.12–4.58) or 
increasing prematurity (36 weeks aOR 2.09, 95% CI 1.36–3.23; 35 
weeks aOR 4.65, 95% CI 2.91–7.52; 34 weeks aOR 25.52, 95% CI 
14.06–47.92) (Table 2). Delivery by caesarean section was not associ-
ated with an increase in neonatal unit admission compared with vaginal 
delivery (pre-labour caesarean section aOR 1.36, 95% CI 0.94–1.98, 
emergency caesarean section aOR 1.40, 95% CI 0.94–2.08). 
4. Discussion 
In women with late preterm preeclampsia, 63% of women delivered 
vaginally after induction of labour. Even at 34 weeks’ gestation, more 
than half of the women induced delivered vaginally. Infants in the 
planned delivery group were more likely to be admitted to the neonatal 
unit at 34 and 35 weeks’ gestation (compared to those managed 
expectantly), but the indication for admission for these infants was most 
frequently attributed to prematurity itself, rather than indicators of 
morbidity. Documented neonatal morbidity at discharge and lengths of 
stay were similar between the groups, suggesting that these admissions 
may reflect clinicians’ behaviour. 
Neonatal unit admission was increased by some factors more com-
mon in the planned delivery group, such as earlier gestation at delivery, 
and by some factors more common in the expectant management group, 
including development of severe preeclampsia, and being small-for- 
gestational age. This demonstrates the need to balance the benefits 
and risks of continuing the pregnancy in a preeclamptic environment, 
with associated maternal and perinatal sequelae, compared to earlier 
delivery by a few days and potential increased neonatal unit admission, 
without additional short-term morbidity. 
This was a prespecified secondary analysis of a large multicentre 
trial, hence the findings are generalisable. Limitations include reporting 
of secondary, descriptive outcomes from the main trial data. 
These findings are supported by other studies in the literature. In a 
retrospective cohort study of women with preterm preeclampsia in a 
broader gestational window (23–36 weeks’ gestation), a 67% vaginal 
delivery rate was reported [5]. Another large retrospective cohort 
demonstrated a reduced risk of neonatal complications (particularly 
self-limiting respiratory conditions of transient tachypnoea and respi-
ratory distress) with induction when compared to planned caesarean 
section in women with preeclampsia beyond 34 weeks’ gestation [6]. 
This secondary analysis adds to the findings of the main trial, and to 
other existing literature, to better inform counselling and shared 
decision-making regarding timing and mode of delivery in this high-risk 
group, stratified by gestational age. The risks and benefits of different 
delivery strategies can now be tailored to an individual woman’s 
gestation, particularly around provision of information that there do not 
appear to be clinically important differences in indicators of neonatal 
morbidity (such as need for respiratory support) across this gestational 
age range. There is still a trade off between increased rates of neonatal 
unit admission (though of shorter median length) at 34 weeks’ gestation 
with planned delivery versus lower rates of small-for-gestational age 
infants with this management strategy. Further studies should consider 
how we improve discrimination of those women and babies at higher 
risk of adverse outcome in late preterm preeclampsia, for more targeted 
and individualised care. 
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